Atlas Venture Life Science Advisors »

Dianthus Therapeutics shares owned by Atlas Venture Life Science Advisors

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Atlas Venture Life Science Advisors from 13F filings

Historical chart of Atlas Venture Life Science Advisors investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Atlas Venture Life Science Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Atlas Venture Life Science Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.1M 77k 27.38
2024-06-30 $3.5M 137k 25.88
2024-03-31 $5.6M 187k 30.00
2023-12-31 $2.5M 237k 10.40
2023-09-30 $3.2M 237k 13.67

More positions owned by Atlas Venture Life Science Advisors

Dyne Therapeutics Common Stock (DYN)
Kymera Therapeutics Common Stock (KYMR)
Third Harmonic Bio Common Stock (THRD)
Disc Medicine Common Stock (IRON)
Q32 Bio Common Stock (QTTB)
Day One Biopharmaceuticals Common Stock (DAWN)
Korro Bio Common Stock (KRRO)
Generation Bio Common Stock (GBIO)
Vigil Neuroscience Common Stock (VIGL)
Tectonic Therapeutics Common Stock (TECX)
Ikena Oncology Common Stock (IKNA)
Aerovate Therapeutics Common Stock (AVTE)
Dianthus Therapeutics Common Stock (DNTH)
Spero Therapeutics Common Stock (SPRO)

View all positions for Atlas Venture Life Science Advisors

Top funds holding Dianthus Therapeutics

FMR
Bain Capital Life Sciences Investors
Avidity Partners Management
Fairmount Funds Management
RA Capital Management
Octagon Capital Advisors
VR Adviser
BlackRock
Vanguard Group
5AM Venture Management
Alliancebernstein
Henderson Group
State Street Corporation
Rtw Investments
Braidwell

View all funds holding Dianthus Therapeutics